<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100279'>Ulcerative colitis</z:hpo> (UC) is a relapsing and remitting disease characterised by <z:hpo ids='HP_0011010'>chronic</z:hpo> mucosal and submucosal <z:mp ids='MP_0001845'>inflammation</z:mp> of the colon and rectum </plain></SENT>
<SENT sid="1" pm="."><plain>Treatment may vary depending upon the extent and severity of <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Broadly speaking medical treatments aim to induce and then maintain remission </plain></SENT>
<SENT sid="3" pm="."><plain>Surgery is indicated for <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disease</z:e> that is refractory to medical treatment or in cases of <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Approximately 25% of patients with UC ultimately require colectomy </plain></SENT>
<SENT sid="5" pm="."><plain>Ileal pouch-anal anastomosis (IPAA) has become the standard of care for patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> who ultimately require colectomy </plain></SENT>
<SENT sid="6" pm="."><plain>This review will examine indications for IPAA, patient selection, technical aspects of surgery, management of complications and long term outcome following this procedure </plain></SENT>
</text></document>